Jazz Pharmaceuticals (JAZZ) Minority Interest (2014 - 2015)
Jazz Pharmaceuticals (JAZZ) posted quarterly Minority Interest of $14000.0 for Q3 2015, down 84.44% year-over-year from $90000.0 in Q3 2014, and down 74.55% quarter-over-quarter from $55000.0 in Q2 2015.
Jazz Pharmaceuticals (JAZZ) Minority Interest (2014 - 2015) Analysis & Trends
Jazz Pharmaceuticals' Minority Interest history runs 2 years deep, the most recent figure standing at $14000.0 for Q3 2015.
- In Q3 2015, Minority Interest fell 84.44% year-over-year to $14000.0; the TTM figure through Sep 2015 stood at $14000.0 (down 84.44% YoY), while the FY2014 annual figure was $64000.0, changed N/A from the prior year.
- Minority Interest for Q3 2015 stood at $14000.0, down from $55000.0 in the prior quarter.
- The five-year high for Minority Interest was $17.6 million in Q1 2014, with the low at $14000.0 in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 14,000.00 |
| Jun 30, 2015 | 55,000.00 |
| Mar 31, 2015 | 54,000.00 |
| Dec 31, 2014 | 64,000.00 |
| Sep 30, 2014 | 90,000.00 |
| Jun 30, 2014 | 396,000.00 |
| Mar 31, 2014 | 17.62 Mn |